Compare FuelCell Energy Inc (FCEL) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FuelCell Energy Inc vs Summit Therapeutics Inc — how do they compare? FuelCell Energy Inc trades at $19.57 (market cap $1.54B), while Summit Therapeutics Inc trades at $15.49 (market cap $12.06B). The key difference: Summit Therapeutics Inc is far larger — about 7.8× FuelCell Energy Inc's market cap, and FuelCell Energy Inc is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| FCEL | SMMT | |
|---|---|---|
Market Cap | $1.54B | $12.06B |
Sector | Industrials | Health |
52-Week High | $36.01 | $26.98 |
52-Week Low | $3.92 | $12.55 |
Enterprise Value | $1.38B | $11.39B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FuelCell Energy (FCEL) trades at $19.83, down 2.94% on the day, with a bearish technical signal and negative profitability metrics. The company reported a net loss of $187.90 million on $158.16 million revenue for 2025, though it beat EPS estimates in two recent quarters. Recent news highlights partnerships with Siemens and AI-driven power demand opportunities, contributing to volatile stock performance.
Outlook remains speculative with high risk due to persistent losses and negative margins, offset by analyst optimism (45% buy rating) and a $20.75 consensus price target. Key risks include cash burn, competitive pressures, and execution challenges in scaling hydrogen technology.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About FuelCell Energy Inc
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products, which efficiently convert chemical energy in fuels into electricity through a series of chemical reactions. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.
Read more on FCEL →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
